Patents by Inventor Marianne Frantsi

Marianne Frantsi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20050004113
    Abstract: There is provided compounds of formula I, wherein R1, R2, R3, R4, R5a, R5b, R5c, R5d, R5e, R5f, R6, X, A, B and D have meanings given in the description, which are useful in the prophylaxis and in the treatment of arrhythmias, in particular atrial and ventricular arrhythmias.
    Type: Application
    Filed: April 26, 2004
    Publication date: January 6, 2005
    Applicant: AstraZeneca AB
    Inventors: Magnus Bjorsne, Marianne Frantsi, Kurt-Jurgen Hoffmann, Bengt Ohlsson
  • Patent number: 6465481
    Abstract: There is provided compounds of formula I, wherein R1, R2, R3, R4, R5a, R5b, R6, R9, X, A and B have meanings given in the description, which are useful in the prophylaxis and in the treatment of arrhythmias, in particular atrial and ventricular arrhythmias.
    Type: Grant
    Filed: September 7, 2000
    Date of Patent: October 15, 2002
    Assignee: AstraZeneca AB
    Inventors: Marianne Frantsi, Kurt-Jürgen Hoffmann, Gert Strandlund
  • Patent number: 6291475
    Abstract: There is provided a compound of formula I, wherein R1, R2, R9, R10, R11, R12, X, A and B have meanings given in the description, which are useful in the prophylaxis and in the treatment of arrhythmias, in particular atrial and ventricular arrhythmias.
    Type: Grant
    Filed: January 12, 1999
    Date of Patent: September 18, 2001
    Assignee: AstraZeneca AB
    Inventors: Christer Alstermark, Annika Björe, Magnus Björsne, Marianne Frantsi, Torbjörn Halvarsson, Kurt-Jürgen Hoffmann, Eva-Lotte Lindstedt, Magnus Polla, Gert Strandlund